Abstract

BackgroundAlzheimer's disease (AD) is a progressive neurodegenerative disease, characterised by the formation of insoluble amyloidogenic plaques and neurofibrillary tangles. Beta amyloid (Aβ) peptide is one of the main constituents in Aβ plaques, and is thought to be a primary causative agent in AD. Neurons are likely to be exposed to chronic, sublethal doses of Aβ over an extended time during the pathogenesis of AD, however most studies published to date using in vitro models have focussed on acute studies. To experimentally model the progressive pathogenesis of AD, we exposed primary cortical neurons daily to 1 μM of Aβ1-40 over 7 days and compared their survival with age-similar untreated cells. We also investigated whether chronic Aβ exposure affects neuronal susceptibility to the subsequent acute excitotoxicity induced by 10 μM glutamate and assessed how Ca2+ and K+ homeostasis were affected by either treatment.ResultsWe show that continuous exposure to 1 μM Aβ1-40 for seven days decreased survival of cultured cortical neurons by 20%. This decrease in survival correlated with increased K+ efflux from the cells. One day treatment with 1 μM Aβ followed by glutamate led to a substantially higher K+ efflux than in the age-similar untreated control. This difference further increased with the duration of the treatment. K+ efflux also remained higher in Aβ treated cells 20 min after glutamate application leading to 2.8-fold higher total K+ effluxed from the cells compared to controls. Ca2+ uptake was significantly higher only after prolonged Aβ treatment with 2.5-fold increase in total Ca2+ uptake over 20 min post glutamate application after six days of Aβ treatment or longer (P < 0.05).ConclusionsOur data suggest that long term exposure to Aβ is detrimental because it reduces the ability of cortical neurons to maintain K+ and Ca2+ homeostasis in response to glutamate challenge, a response that might underlie the early symptoms of AD. The observed inability to maintain K+ homeostasis might furthermore be useful in future studies as an early indicator of pathological changes in response to Aβ.

Highlights

  • Alzheimer’s disease (AD) is a progressive neurodegenerative disease, characterised by the formation of insoluble amyloidogenic plaques and neurofibrillary tangles

  • Cortical neurons were maintained for 6 days in vitro (DIV), by which time they had formed a dense meshwork of neuritic processes

  • Acute exposure to low doses of Ab1-40 does not change K + and Ca2+ fluxes from neurons Inability to maintain Ca2+ homeostasis has been strongly implicated in AD [12,13,14]

Read more

Summary

Introduction

Alzheimer’s disease (AD) is a progressive neurodegenerative disease, characterised by the formation of insoluble amyloidogenic plaques and neurofibrillary tangles. Beta amyloid (Ab) peptide is one of the main constituents in Ab plaques, and is thought to be a primary causative agent in AD. To experimentally model the progressive pathogenesis of AD, we exposed primary cortical neurons daily to 1 μM of Ab1-40 over 7 days and compared their survival with age-similar untreated cells. There appears to be a gradual progression of the disease which involves the accumulation of soluble Ab within the brain due to the chronic imbalance between production and clearance of Ab. Instead, there appears to be a gradual progression of the disease which involves the accumulation of soluble Ab within the brain due to the chronic imbalance between production and clearance of Ab This gradual accumulation of Ab over extended periods of time leads to the formation of the insoluble Ab aggregates which form the characteristic plaques, but it modifies neuronal function. Synthetic Ab peptides were toxic to hippocampal and cortical neurons in culture [5,6]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.